236 related articles for article (PubMed ID: 37612508)
1. Non-cell-autonomous cancer progression from chromosomal instability.
Li J; Hubisz MJ; Earlie EM; Duran MA; Hong C; Varela AA; Lettera E; Deyell M; Tavora B; Havel JJ; Phyu SM; Amin AD; Budre K; Kamiya E; Cavallo JA; Garris C; Powell S; Reis-Filho JS; Wen H; Bettigole S; Khan AJ; Izar B; Parkes EE; Laughney AM; Bakhoum SF
Nature; 2023 Aug; 620(7976):1080-1088. PubMed ID: 37612508
[TBL] [Abstract][Full Text] [Related]
2. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
Hong C; Schubert M; Tijhuis AE; Requesens M; Roorda M; van den Brink A; Ruiz LA; Bakker PL; van der Sluis T; Pieters W; Chen M; Wardenaar R; van der Vegt B; Spierings DCJ; de Bruyn M; van Vugt MATM; Foijer F
Nature; 2022 Jul; 607(7918):366-373. PubMed ID: 35705809
[TBL] [Abstract][Full Text] [Related]
3. The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability.
Hong C; Tijhuis AE; Foijer F
Cells; 2019 Oct; 8(10):. PubMed ID: 31658669
[TBL] [Abstract][Full Text] [Related]
4. cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
Beernaert B; Parkes EE
Biochem Soc Trans; 2023 Apr; 51(2):539-555. PubMed ID: 36876871
[TBL] [Abstract][Full Text] [Related]
5. The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment.
Bakhoum SF; Cantley LC
Cell; 2018 Sep; 174(6):1347-1360. PubMed ID: 30193109
[TBL] [Abstract][Full Text] [Related]
6. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
[TBL] [Abstract][Full Text] [Related]
7. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression.
Bakhoum MF; Francis JH; Agustinus A; Earlie EM; Di Bona M; Abramson DH; Duran M; Masilionis I; Molina E; Shoushtari AN; Goldbaum MH; Mischel PS; Bakhoum SF; Laughney AM
Nat Commun; 2021 Sep; 12(1):5402. PubMed ID: 34518527
[TBL] [Abstract][Full Text] [Related]
8. Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer.
Sokač M; Ahrenfeldt J; Litchfield K; Watkins TBK; Knudsen M; Dyrskjøt L; Jakobsen MR; Birkbak NJ
Cancer Res Commun; 2022 Aug; 2(8):762-771. PubMed ID: 36923311
[TBL] [Abstract][Full Text] [Related]
9. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling.
Ghosh MK; Roy S
Mol Biomed; 2024 Jan; 5(1):4. PubMed ID: 38253764
[No Abstract] [Full Text] [Related]
11. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
Wheeler OPG; Unterholzner L
Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
[TBL] [Abstract][Full Text] [Related]
12. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal instability drives metastasis through a cytosolic DNA response.
Bakhoum SF; Ngo B; Laughney AM; Cavallo JA; Murphy CJ; Ly P; Shah P; Sriram RK; Watkins TBK; Taunk NK; Duran M; Pauli C; Shaw C; Chadalavada K; Rajasekhar VK; Genovese G; Venkatesan S; Birkbak NJ; McGranahan N; Lundquist M; LaPlant Q; Healey JH; Elemento O; Chung CH; Lee NY; Imielenski M; Nanjangud G; Pe'er D; Cleveland DW; Powell SN; Lammerding J; Swanton C; Cantley LC
Nature; 2018 Jan; 553(7689):467-472. PubMed ID: 29342134
[TBL] [Abstract][Full Text] [Related]
14. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
[TBL] [Abstract][Full Text] [Related]
15. cGAS-STING and the deadly CIN: how chronic inflammation represents a therapeutic vulnerability in chromosomally unstable cancers.
Bakhoum SF
Trends Cancer; 2022 Oct; 8(10):788-789. PubMed ID: 35915014
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
[TBL] [Abstract][Full Text] [Related]
17. Taking the STING out of CIN.
van den Brink A; Foijer F
Trends Cancer; 2023 Dec; 9(12):992-994. PubMed ID: 37806895
[TBL] [Abstract][Full Text] [Related]
18. The immunological consequences of radiation-induced DNA damage.
Wilkins AC; Patin EC; Harrington KJ; Melcher AA
J Pathol; 2019 Apr; 247(5):606-614. PubMed ID: 30632153
[TBL] [Abstract][Full Text] [Related]
19. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
Chen B; Dragomir MP; Fabris L; Bayraktar R; Knutsen E; Liu X; Tang C; Li Y; Shimura T; Ivkovic TC; De Los Santos MC; Anfossi S; Shimizu M; Shah MY; Ling H; Shen P; Multani AS; Pardini B; Burks JK; Katayama H; Reineke LC; Huo L; Syed M; Song S; Ferracin M; Oki E; Fromm B; Ivan C; Bhuvaneshwar K; Gusev Y; Mimori K; Menter D; Sen S; Matsuyama T; Uetake H; Vasilescu C; Kopetz S; Parker-Thornburg J; Taguchi A; Hanash SM; Girnita L; Slaby O; Goel A; Varani G; Gagea M; Li C; Ajani JA; Calin GA
Gastroenterology; 2020 Dec; 159(6):2146-2162.e33. PubMed ID: 32805281
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancer.
Martin JC; da Silva Fernandes T; Chaudhry KA; Oshi M; Abrams SI; Takabe K; Rosario SR; Bianchi-Smiraglia A
Sci Rep; 2024 Mar; 14(1):5731. PubMed ID: 38459088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
